Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Vahdat

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2008
Growth of uterine leiomyomata among premenopausal black and white womenShyamal D Peddada, Shannon K Laughlin, Kelly Miner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Reduction of paclitaxel-induced peripheral neuropathy with glutamineL Vahdat, K Papadopoulos, D Lange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancerJ S Jacobson, A B Troxel, J Evans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2021
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trialA Bardia, W A Messersmith, E A Kio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2021
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancerA Bardia, S M Tolaney, K Punie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02S A Hurvitz, S Loi, J O'Shaughnessy, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2008
Growth of uterine leiomyomata among premenopausal black and white womenShyamal D Peddada, Shannon K Laughlin, Kelly Miner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Reduction of paclitaxel-induced peripheral neuropathy with glutamineL Vahdat, K Papadopoulos, D Lange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancerJ S Jacobson, A B Troxel, J Evans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2021
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trialA Bardia, W A Messersmith, E A Kio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2021
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancerA Bardia, S M Tolaney, K Punie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02S A Hurvitz, S Loi, J O'Shaughnessy, et al.
Pageof 3